<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02064192</url>
  </required_header>
  <id_info>
    <org_study_id>EU 602299</org_study_id>
    <nct_id>NCT02064192</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe</brief_title>
  <acronym>EU-CERT-ICD</acronym>
  <official_title>Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The &quot;EUropean Comparative Effectiveness Research to assess the use of primary prophylacTic
      Implantable Cardioverter Defibrillators (EU-CERT-ICD)&quot; is a modular research project to study
      the effectiveness of prophylactic ICDs in a prospective study, a retrospective registry, and
      meta-analyses of existing evidence on the subject.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prospective study part is an observational, prospective multi-centre study which aims to
      enrol 2500 patients with ischemic or dilated cardiomyopathy and primary prophylactic ICD
      indication for reduced left ventricular ejection fraction (LVEF) according to current
      guidelines. According to the treating physician's decision and preference which is
      independent from study participation, patients are recruited into one of two groups: patients
      directly prior to first ICD implantation (ICD Group), or patients who are not considered for
      prophylactic ICD treatment by the physician or are considered but refuse ICD treatment
      (Control Group). Patients will undergo simple 12-lead electrocardiogram (ECG) and Holter ECG
      diagnostics at baseline as well as genetic biobanking at entry to the study. All patients
      will be subsequently followed for at least 1 year and up to 4 years. Co-primary endpoints are
      all-cause mortality and appropriate ICD shocks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-Cause Mortality</measure>
    <time_frame>one to four years</time_frame>
    <description>Co-Primary Endpoint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First Appropriate ICD Shock</measure>
    <time_frame>one to four years</time_frame>
    <description>Co-Primary Endpoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First Inappropriate Shock</measure>
    <time_frame>one to four years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sudden Cardiac Death</measure>
    <time_frame>one to four years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Death</measure>
    <time_frame>one to four years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-Cardiac Death</measure>
    <time_frame>one to four years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arrhythmogenic Syncope</measure>
    <time_frame>one to four years</time_frame>
    <description>presumed arrhythmogenic syncopes (per the judgment of each investigator and the endpoint committee)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resuscitation</measure>
    <time_frame>one to four years</time_frame>
    <description>successful resuscitation for ventricular tachyarrhythmias (especially in the non ICD Control Group)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any ICD Shock</measure>
    <time_frame>one to four years</time_frame>
    <description>any ICD shock (appropriate or inappropriate)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial Fibrillation</measure>
    <time_frame>one to four years</time_frame>
    <description>atrial fibrillation (if documented), defined as an atrial tachyarrhythmia &gt;250 beats per minute (bpm) lasting at least 30 seconds is considered as secondary endpoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>one to four years</time_frame>
    <description>quality of life (QoL) will be assessed using the questionnaires SF 36, MacNew and Florida Patient Acceptance Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Revision / Device Replacement</measure>
    <time_frame>one to four years</time_frame>
    <description>the secondary endpoint Device Revision/Replacement will be recorded as electrode dislocation/revision, device revision for pocket hematoma, perforation, or infection, device exchange due to malfunction, battery exhaustion, other reason, or upgrade to dual chamber or CRT-D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs and Cost-Effectiveness</measure>
    <time_frame>one to four years</time_frame>
    <description>the secondary endpoint &quot;Costs&quot; will be assessed using patient questionnaires to the German-speaking study sites, an extension to other participating countries will be decided during the study, the assessment of cost-effectiveness will be realised by comparing cost-results with regard to changes in QoL</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Dilated Cardiomyopathy</condition>
  <condition>Implantable Defibrillator User</condition>
  <arm_group>
    <arm_group_label>ICD Group (n=1500)</arm_group_label>
    <description>First ICD device implantation (after baseline assessments) is not part of this observational study and is carried out in the responsibility of the treating physician, all ICD-devices will undergo unique standard programming to ensure comparability of ICD shock events between patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group (n=750)</arm_group_label>
    <description>Patients who fulfill inclusion criteria but do not receive an ICD device will be followed as part of the Control Group</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood sample for genetic analysis
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are eligible for primary prophylactic ICD implantation and potentially
        eligible for study participation will be identified based on echocardiographic and/or 12
        lead ECG results. For ICD Group patients, screening will be shortly before scheduled ICD
        implantation. For Control Group patients, the time span between primary diagnosis of
        eligibility for primary ICD implantation and the date of the primary diagnosis of
        cardiomyopathy must be recorded in the eCRF, together with how and when the decision not to
        prescribe a defibrillator was reached. Control group will be recruited from patients with
        ischemic or dilated cardiomyopathies and LVEF ≤ 35%. Patients scheduled for ICD
        implantation (ICD Group) undergo screening and baseline assessments prior to ICD
        implantation. Patients for the Control Group will undergo baseline assessments as soon as
        possible after screening. Baseline assessments are identical for the ICD Group and the
        Control Group.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic or dilated cardiomyopathy and recommendation for primary prophylactic ICD
             treatment following current international treatment guidelines

          -  Written informed consent

          -  If ICD implantation is planned, enrollment and study baseline testing needs to be
             completed before de-novo ICD implantation

        Exclusion Criteria:

          -  Permanent atrial fibrillation or atrial fibrillation at baseline in case more than 15%
             of such patients at a given time have been enrolled

          -  Indication for secondary prophylactic ICD treatment

          -  Indication or candidate for cardiac resynchronization therapy

          -  AV block II°-III° at resting heart rates

          -  Implanted pacemaker

          -  Unstable cardiac disease such as decompensated heart failure (NYHA functional class
             IV) or acute coronary syndrome

          -  Participation in other clinical trials which exclude enrolment in other trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Zabel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Goettingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leonard Bergau, MD</last_name>
    <phone>+49 551 3910265</phone>
    <email>leonard.bergau@med.uni-goettingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Simon C Schlögl, MD</last_name>
    <phone>+49 551 3965255</phone>
    <email>simon.schloegl@med.uni-goettingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KU Leuven, Div. of Cardiology</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rik Willems, MD, PhD</last_name>
      <email>rik.willems@med.kuleuven.be</email>
    </contact>
    <investigator>
      <last_name>Rik Willems, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bert Vandenberk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Heart Hospital, Dept. of Cardiology</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tchavdar Shalganov, MD</last_name>
      <phone>+359 2 9211211</phone>
      <email>tchavdar.shalganov@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tchavdar Shalganov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Acibadem City Clinic Tokuda Hospital, Div. of Cardiology</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vassil Traykov, MD</last_name>
      <phone>+359 2 403 4000</phone>
      <email>vtraykov@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Vassil Traykov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Ekaterina Hospital, Div. of Cardiology</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Svetoslav Iovev, MD</last_name>
      <phone>+359 700 12 131</phone>
      <email>sviovev@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Svetoslav Iovev, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Anna University Hospital for Active Treatment, Div. of Cardiology</name>
      <address>
        <city>Sofia</city>
        <zip>1709</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasil Velchev, MD</last_name>
      <phone>+359 2 9759000</phone>
      <email>velchevvasil@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vasil Velchev, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Magdalena Clinic</name>
      <address>
        <city>Krapinske Toplice</city>
        <zip>49217</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janko Szavits-Nossan, MD</last_name>
      <phone>+38 54 9244 115</phone>
      <email>janko.szavits-nossan@magdalena.hr</email>
    </contact>
    <investigator>
      <last_name>Janko Szavits-Nossan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinički bolnički centar Rijeka, Div. of Cardiology</name>
      <address>
        <city>Rijeka</city>
        <zip>51000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandro Brusich, MD</last_name>
      <phone>+385 51 407 149</phone>
      <email>sandro.brusich@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sandro Brusich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinički bolnički centar Split, Div. of Cardiology</name>
      <address>
        <city>Split</city>
        <zip>21000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zrinka Jurisic, MD</last_name>
      <phone>+385 21 556 111</phone>
      <email>zrinkacn@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Zrinka Jurisic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Opća Bolnica Zadar, Div. of Cardiology</name>
      <address>
        <city>Zadar</city>
        <zip>23000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoran Bakotic, MD</last_name>
      <phone>+385 23 505 505</phone>
      <email>zbakotic@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Zoran Bakotic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ante Anic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinički bolnički centar Sestre milosrdnice, Div. of Cardiology</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikola Pavlovic, MD</last_name>
      <phone>+385 91 5983 581‬</phone>
      <email>nikolap12@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Nikola Pavlovic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Masaryk University Hospital Brno, Div. of Cardiology</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomas Novotny, MD</last_name>
      <phone>+420-532-231111</phone>
      <email>novotny-t@seznam.cz</email>
    </contact>
    <investigator>
      <last_name>Milan Kozak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Novotny, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palacky University Hospital Olomouc, Div. of Cardiology</name>
      <address>
        <city>Olomouc</city>
        <zip>77147</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milos Taborsky, MD</last_name>
      <phone>+420-588-443201</phone>
      <email>Milos.Taborsky@fnol.cz</email>
    </contact>
    <investigator>
      <last_name>Milos Taborsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Galuszka, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet, Div. of Cardiology</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesper Hastrup Svendsen, MD</last_name>
      <phone>+45 3545 2735</phone>
      <email>jesper.hastrup.svendsen@rh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Jesper Hastrup Svendsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gentofte Hospital, Div. of Cardiology</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jim Hansen, MD</last_name>
      <phone>+45-38-673331</phone>
      <email>Jim.Hansen@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Julie Laage-Petersen, RN</last_name>
      <phone>+45-38-673331</phone>
      <email>Julie.Laage-Petersen@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Jim Hansen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, University of Oulu</name>
      <address>
        <city>Oulu</city>
        <zip>90014</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heikki V Huikuri, MD</last_name>
      <phone>+ 35 88 3154108</phone>
      <email>heikki.huikuri@oulu.fi</email>
    </contact>
    <investigator>
      <last_name>Heikki V Huikuri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tuomas Kenttä, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juhani Junttila, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CharitéCentrum 1 Health and Human Sciences, Institute for Social Medicine, Epidemiology and Health Economics</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charitè Virchow Klinikum (CVK), Div. of Cardiology</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Blaschke, MD</last_name>
      <phone>+49 30 450 553 635</phone>
      <email>florian.blaschke@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Burkert Pieske, MD</last_name>
      <phone>+49 30 450 553 702</phone>
      <email>burkert.pieske@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Florian Blaschke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vivantes Humboldt Klinikum, Div. of Cardiology</name>
      <address>
        <city>Berlin</city>
        <zip>13509</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Marien-Hospital, Div. of Cardiology</name>
      <address>
        <city>Bonn</city>
        <zip>53115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dieter Bimmel, MD</last_name>
      <phone>+49-228-5050</phone>
      <email>Dr.Dieter.Bimmel@marien-hospital-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Dieter Bimmel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Reinkenheide, Div. of Cardiology</name>
      <address>
        <city>Bremerhaven</city>
        <zip>27574</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rüdiger Dissmann, MD</last_name>
      <phone>+49-471-2993365</phone>
      <email>ruediger.dissmann@klinikum-bremerhaven.de</email>
    </contact>
    <investigator>
      <last_name>Rüdiger Dissmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center, Div. of Cardiology</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Zabel, MD</last_name>
      <phone>+49 551 3910265</phone>
      <email>markus.zabel@med.uni-goettingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Rajevaa Sritharan, MSc</last_name>
      <phone>+49 551 3910475</phone>
      <email>rajevaa.sritharan@med.uni-goettingen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Lars Lüthje, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleksandra Kirova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonard Bergau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markus Zabel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon C Schlögl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinikum Barmbek, Div. of Cardiology</name>
      <address>
        <city>Hamburg</city>
        <zip>22307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herz im Zentrum</name>
      <address>
        <city>Hannover</city>
        <zip>30159</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Westpfalz-Klinikum, Div. of Cardiology</name>
      <address>
        <city>Kaiserslautern</city>
        <zip>67655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Karlsruhe, Div. of Cardiology</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg, Div. of Cardiology</name>
      <address>
        <city>Ludwigsburg</city>
        <zip>71640</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norman Rüb, MD</last_name>
      <phone>+49-7141-9996527</phone>
      <email>norman.rueb@kliniken-lb.de</email>
    </contact>
    <contact_backup>
      <last_name>Christian Wolpert, MD</last_name>
      <phone>+49-7141-9967301</phone>
      <email>christian.wolpert@kliniken-lb.de</email>
    </contact_backup>
    <investigator>
      <last_name>Norman Rüb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Cardiovascular Diseases, German Heart Centre Munich, Technische Universität München</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Schmidt, MD</last_name>
      <phone>+49 89 4140 2352</phone>
      <email>gschmidt@tum.de</email>
    </contact>
    <investigator>
      <last_name>Georg Schmidt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Sinnecker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Müller, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Dommasch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ludwig-Maximilians-University, Div. of Cardiology</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kääb, MD</last_name>
      <phone>+49-89-7095-6159</phone>
      <email>stefan.kaab@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Kääb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moritz F Sinner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Axel Bauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Regensburg, Div. of Cardiology</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Seegers, MD</last_name>
      <phone>+49 941 944-7183</phone>
      <email>Joachim.Seegers@klinik.uni-regensburg.de</email>
    </contact>
    <investigator>
      <last_name>Joachim Seegers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Tuebingen, Div. of Cardiology</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Eick, MD</last_name>
      <email>christian.eick@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Eick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Weiden, Div. of Cardiology</name>
      <address>
        <city>Weiden</city>
        <zip>92637</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Attikon University Hospital, Div. of Cardiology</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Panagiota Flevari, MD</last_name>
      <email>pflevari@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Dimitrios Katsaras, MD</last_name>
      <email>d_katsaras@yahoo.gr</email>
    </contact_backup>
    <investigator>
      <last_name>Panagiota Flevari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Béla Merkely, MD, PhD, DSc</last_name>
      <phone>+36 1 458 6810</phone>
      <email>merkely.bela@kardio.sote.hu</email>
    </contact>
    <investigator>
      <last_name>Béla Merkely, MD, PhD, DSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gábor Széplaki, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Perge, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht, Dept. of Physiology &amp; Cardiology</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc A Vos, PhD</last_name>
      <phone>+31 30 253 8900</phone>
      <email>m.a.vos@umcutrecht.nl</email>
    </contact>
    <contact_backup>
      <last_name>Jeannette Visser-Bouman, RN</last_name>
      <phone>+31 88 7559433</phone>
    </contact_backup>
    <investigator>
      <last_name>Marc A Vos, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anton E Tuinenburg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Sprenkeler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Lodz</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrzej Lubinski, MD</last_name>
      <email>lubinski.a@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrzej Lubinski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iwona Cygankiewicz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaroslav Kasprzak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heliodor Swiecicki University Hospital, Div. of Cardiology</name>
      <address>
        <city>Poznan</city>
        <zip>60355</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Przemyslav Guzik, MD, PhD</last_name>
      <phone>+48 61 8691391</phone>
      <email>pguzik@ptkardio.pl</email>
    </contact>
    <investigator>
      <last_name>Przemyslav Guzik, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardinal Stefan Wyszynski Institute of Cardiology (IKARD)</name>
      <address>
        <city>Warszawa</city>
        <zip>04628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stredoslovenský ústav srdcových a cievnych chorôb (SUSSCH)</name>
      <address>
        <city>Banska Bystrica</city>
        <zip>97401</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Kaliska, MD</last_name>
      <phone>+ 421-48-4333111</phone>
      <email>Gabriela.Kaliska@suscch.eu</email>
    </contact>
    <investigator>
      <last_name>Gabriela Kaliska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Slovak Medical University, Heart Center</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hatala, MD</last_name>
      <email>robert.hatala@nusch.sk</email>
    </contact>
    <investigator>
      <last_name>Robert Hatala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Svetlosak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic, Universitat de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josep Brugada, MD</last_name>
      <email>jbrugada@clinic.ub.es</email>
    </contact>
    <investigator>
      <last_name>Josep Brugada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Arbelo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilce Trucco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skane University Hospital, Div. of Cardiology</name>
      <address>
        <city>Lund</city>
        <zip>22241</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Karolinska Institute, Div. of Cardiology</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frieder Braunschweig, MD, PhD</last_name>
      <phone>+46-8-51771629</phone>
      <email>frieder.braunschweig@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Frieder Braunschweig, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel, Div. of Cardiology</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Sticherling, MD</last_name>
      <phone>+41-61-556 5817</phone>
      <email>csticherling@uhbs.ch</email>
    </contact>
    <investigator>
      <last_name>Christian Sticherling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David C Conen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Paul's Cardiac Electrophysiology</name>
      <address>
        <city>London</city>
        <state>Purley, Surrey</state>
        <zip>CR8 3NQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>http://www.eu-cert-icd.eu</url>
    <description>EU-CERT-ICD Website</description>
  </link>
  <reference>
    <citation>Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K, Goff DC, Hirsch AT, Hylek EM, Peterson ED, Roger VL, Selby JV, Udelson JE, Lauer MS. Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2012 Aug 14;60(7):569-80. doi: 10.1016/j.jacc.2011.12.057. Epub 2012 Jul 11.</citation>
    <PMID>22796257</PMID>
  </reference>
  <reference>
    <citation>Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001 Nov 15;345(20):1473-82. Review.</citation>
    <PMID>11794197</PMID>
  </reference>
  <reference>
    <citation>Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225-37. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.</citation>
    <PMID>15659722</PMID>
  </reference>
  <reference>
    <citation>Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.</citation>
    <PMID>18391108</PMID>
  </reference>
  <reference>
    <citation>Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058. Review.</citation>
    <PMID>18804736</PMID>
  </reference>
  <reference>
    <citation>Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012 Dec 13;367(24):2275-83. doi: 10.1056/NEJMoa1211107. Epub 2012 Nov 6.</citation>
    <PMID>23131066</PMID>
  </reference>
  <reference>
    <citation>MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Calzavara AJ, Austin PC, Tu JV, Lee DS. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med. 2012 Feb 7;156(3):195-203. doi: 10.7326/0003-4819-156-3-201202070-00007.</citation>
    <PMID>22312139</PMID>
  </reference>
  <reference>
    <citation>Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace. 2009 Jun;11(6):716-26. doi: 10.1093/europace/eup068. Epub 2009 Apr 9.</citation>
    <PMID>19359333</PMID>
  </reference>
  <reference>
    <citation>Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm. 2012 Jan;9(1):42-6. doi: 10.1016/j.hrthm.2011.08.031. Epub 2011 Sep 3.</citation>
    <PMID>21893137</PMID>
  </reference>
  <reference>
    <citation>Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA. 2013 Jan 2;309(1):55-62. doi: 10.1001/jama.2012.157182.</citation>
    <PMID>23280225</PMID>
  </reference>
  <reference>
    <citation>Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schömig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999 Apr 24;353(9162):1390-6.</citation>
    <PMID>10227219</PMID>
  </reference>
  <reference>
    <citation>Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, Hnatkova K, Schömig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006 May 20;367(9523):1674-81.</citation>
    <PMID>16714188</PMID>
  </reference>
  <reference>
    <citation>Zabel M, Malik M, Hnatkova K, Papademetriou V, Pittaras A, Fletcher RD, Franz MR. Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation. 2002 Mar 5;105(9):1066-70.</citation>
    <PMID>11877356</PMID>
  </reference>
  <reference>
    <citation>Thomsen MB, Volders PG, Beekman JD, Matz J, Vos MA. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol. 2006 Sep 19;48(6):1268-76. Epub 2006 Aug 28.</citation>
    <PMID>16979017</PMID>
  </reference>
  <reference>
    <citation>Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007 Dec 11;50(24):2275-84. Epub 2007 Nov 26.</citation>
    <PMID>18068035</PMID>
  </reference>
  <reference>
    <citation>Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, Müller-Nurasyid M, Krijthe BP, Lubitz SA, Bis JC, Chung MK, Dörr M, Ozaki K, Roberts JD, Smith JG, Pfeufer A, Sinner MF, Lohman K, Ding J, Smith NL, Smith JD, Rienstra M, Rice KM, Van Wagoner DR, Magnani JW, Wakili R, Clauss S, Rotter JI, Steinbeck G, Launer LJ, Davies RW, Borkovich M, Harris TB, Lin H, Völker U, Völzke H, Milan DJ, Hofman A, Boerwinkle E, Chen LY, Soliman EZ, Voight BF, Li G, Chakravarti A, Kubo M, Tedrow UB, Rose LM, Ridker PM, Conen D, Tsunoda T, Furukawa T, Sotoodehnia N, Xu S, Kamatani N, Levy D, Nakamura Y, Parvez B, Mahida S, Furie KL, Rosand J, Muhammad R, Psaty BM, Meitinger T, Perz S, Wichmann HE, Witteman JC, Kao WH, Kathiresan S, Roden DM, Uitterlinden AG, Rivadeneira F, McKnight B, Sjögren M, Newman AB, Liu Y, Gollob MH, Melander O, Tanaka T, Stricker BH, Felix SB, Alonso A, Darbar D, Barnard J, Chasman DI, Heckbert SR, Benjamin EJ, Gudnason V, Kääb S. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012 Apr 29;44(6):670-5. doi: 10.1038/ng.2261.</citation>
    <PMID>22544366</PMID>
  </reference>
  <reference>
    <citation>Seegers J, Vos MA, Flevari P, Willems R, Sohns C, Vollmann D, Lüthje L, Kremastinos DT, Floré V, Meine M, Tuinenburg A, Myles RC, Simon D, Brockmöller J, Friede T, Hasenfuß G, Lehnart SE, Zabel M; EUTrigTreat Clinical Study Investigators. Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace. 2012 Mar;14(3):416-22. doi: 10.1093/europace/eur352. Epub 2011 Nov 23.</citation>
    <PMID>22117037</PMID>
  </reference>
  <reference>
    <citation>Buxton AE. Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit. J Am Coll Cardiol. 2012 Oct 23;60(17):1656-8. doi: 10.1016/j.jacc.2012.06.041. Epub 2012 Sep 26.</citation>
    <PMID>23021332</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2014</study_first_submitted>
  <study_first_submitted_qc>February 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2014</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Markus Zabel</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>defibrillator, implantable cardioverter</keyword>
  <keyword>sudden cardiac death</keyword>
  <keyword>primary prophylaxis</keyword>
  <keyword>risk stratification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

